PS-2100

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePS-2100

Drug Alias Nameprostate cancer cell therapy (Immunobar)PS-2100

ClassificationCell and gene therapy > Cell therapyVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesImmunobar

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesImmunobar

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A